Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder

Journal of Clinical Psychiatry

Volumn 71, Issue 11, 2010, Pages 1535-1551

  Waxmonsky, James G ^a,b   Waschbusch, Daniel A ^a,b   Pelham, William E ^a,b   Draganac Cardona, Lillian ^a   Rotella, Bryan ^a   Ryan, Lynn ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

ACADEMIC ACHIEVEMENT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CHILD PARENT RELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; FATIGUE; FEMALE; HOME; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL; SCHOOL CHILD; SIDE EFFECT; SOCIAL ADAPTATION; STOMACH PAIN; TEACHER;

ACTIVITIES OF DAILY LIVING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; SCHOOLS; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 78649784132     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05496pur     Document Type: Article

References (86)

1. Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004;114(1):e1-e8.
2. Michelson D, Faries D, Wernicke J, et al. Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108(5):E83.
3. Newcorn JH. Efficacy trials of atomoxetine for ADHD in children, adolescents and adults [abstract]. Presented at the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 22-27, 2002; San Francisco, CA.
4. Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(12):1140-1147.
5. Weiss M, Tannock R, Kratochvil C, et al. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005;44(7):647-655.
6. Perwien AR, Faries DE, Kratochvil CJ, et al. Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine. J Dev Behav Pediatr. 2004;25(4): 264-271.
7. Bussing R, Koro-Ljungberg ME, Gary FA, et al. Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv Rev Psychiatry. 2005;13(2):85-101.
8. Charach A, Skyba A, Cook L, et al. Using stimulant medication for children with ADHD: what do parents say? a brief report. J Can Acad Child Adolesc Psychiatry. 2006;15(2):75-83.
9. Fabiano GA, Pelham WEJ Jr, Coles EK, et al. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009;29(2):129-140.
10. Pelham WE Jr, Fabiano GA. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2008;37(1):184-214.
11. Jurbergs N, Kelley ML. Daily report cards. In: McBurnett K, Pfiffner LJ, eds. Attention-Deficit/Hyperactivity Disorder: Concepts, Controversies, New Directions. New York, NY: Informa Healthcare; 2008:161-168.
12. Fabiano GA, Pelham WE, Gnagy EM, et al. The single and combined effects of multiple intensities of behavior modification and methyl-phenidate for children with attention deficit hyperactivity disorder in a classroom setting. School Psych Rev. 2007;36(2):195-216.
13. Fabiano GA, Pelham WE, Waschbusch DA, et al. Enhancing the effectiveness of special education programming for children with attention-deficit/ hyperactivity disorder using a daily report card. School Psych Rev. In press.
14. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159(11):1896-1901.
15. Michelson D, Buitelaar JK, Danckaerts M, et al. Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004;43(7):896-904.
16. Buitelaar JK, Michelson D, Danckaerts M, et al. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry. 2007;61(5):694-699.
17. Cheng JYW, Chen RYL, Ko JSN, et al. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents - meta-analysis and meta-regression analysis. Psychopharmacology (Berl). 2007;194(2):197-209.
18. Schachar R, Tannock R. Childhood hyperactivity and psychostimulants: a review of extended treatment studies. J Child Adolesc Psychopharmacol. 1993;3(2):81-97.
19. Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007;46(8):989-1002.
20. Pelham WE, Waschbusch DA. Behavioral intervention in ADHD. In: Quay HC, Hogan AE, eds. Handbook of Disruptive Behavior Disorders. New York, NY: Plenum; 1999:255-278.
21. Abikoff HB, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43(7):802-811. doi:10.1097/01.chi.0128791.1014.ac PubMed (Pubitemid 38808485)
22. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086.
23. Kolko DJ, Bukstein OG, Barron J. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. J Am Acad Child Adolesc Psychiatry. 1999;38(5):578-586.
24. Carlson CL, Pelham WE Jr, Milich R, et al. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention-deficit hyperactivity disorder. J Abnorm Child Psychol. 1992;20(2):213-232.
25. Pelham WE Jr, Carlson C, Sams SE, et al. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. J Consult Clin Psychol. 1993;61(3):506-515.
26. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40(2):168-179.
27. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921.
28. Svanborg P, Thernlund G, Gustafsson PA, et al. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. Eur Child Adolesc Psychiatry. 2009;18(4):240-249.
29. Waschbusch DA, Pelham WE Jr, Waxmonsky J, et al. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2009;30(2):158-168.
30. Konrad K, Günther T, Heinzel-Gutenbrunner M, et al. Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc Psychopharmacol. 2005;15(2):180-190.
31. Abikoff HB, Courtney M, Pelham WE Jr, et al. Teachers' ratings of disruptive behaviors: the influence of halo effects. J Abnorm Child Psychol. 1993;21(5):519-533.
32. Stevens J, Quittner AL, Abikoff H. Factors influencing elementary school teachers' ratings of ADHD and ODD behaviors. J Clin Child Psychol. 1998;27(4):406-414.
33. Pelham WE, Fabiano GA, Massetti GM. Evidence-based assessment for attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc. 2005;34(3):449-476.
34. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. New York, NY: Psychological Corporation; 1991.
35. Psychological Corporation. Wechsler Individual Achievement Test. 2nd ed. San Antonio, TX: Psychological Corporation; 2002.
36. Nakao K, Treas J. Updating occupational prestige and socioeconomic status: how the new measures measure up. Sociol Methodol. 1994;24:1-72.
37. Pelham WE Jr, Gnagy EM, Greenslade KE, et al. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry. 1992;31(2):210-218.
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
39. NIMH-DISC Editorial Board. The National Institute of Mental Health Diagnostic Interview Schedule for Children. New York, NY: Columbia University; 1999.
40. Pelham WE. Disruptive Behavior Disorders Interview. Buffalo, NY: Comprehensive Treatment for Attention Deficit Disorders, Inc; 1998.
41. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
42. Cunningham CE, Bremner RB, Secord M. The Community Parent Education Program (COPE): A School-Based Family Systems Oriented Workshop for Parents of Children With Disruptive Behavior Disorders (leader's manual). Hamilton, Ontario, Canada: COPE Works; 1998.
43. Cunningham CE, Bremner R, Boyle M. Large group community-based parenting programs for families of preschoolers at risk for disruptive behaviour disorders: utilization, cost effectiveness, and outcome. J Child Psychol Psychiatry. 1995;36(7):1141-1159.
44. Pelham WE, Gnagy EM, Greiner AR, et al. Summer treatment programs for attention- deficit/hyperactivity disorder. In: Weisz JR, Kazdin AE, eds. Evidence-Based Psychotherapies for Children and Adolescents. 2nd ed. New York, NY: Guilford Press; 2010;277.
45. Pelham WE, Gnagy EM, Greiner AR. Children's Summer Day Treatment Program Manual. Buffalo, NY: Comprehensive Treatment for Attention Deficit Disorders, Inc; 1998.
46. Pelham WE, Massetti GM, Waschbusch DA, et al. Effects of a school-wide social and character development intervention in children with disruptive behavior problems [abstract]. Presented at the Annual Research Conference of the Institute of Education Sciences; June 10-12, 2008; Washington, DC.
47. Massetti GM, Pelham WE, Gnagy EM. Situational variability of ADHD, ODD, and CD: psychometric properties of the DBD interview and rating scale for an ADHD sample [abstract]. Presented at the Annual Meeting of the International Society for Research in Child and Adolescent Psychopathology; June 2005; New York, NY.
48. Pillow DR, Pelham WE Jr, Hoza B, et al. Confirmatory factor analyses examining attention deficit hyperactivity disorder symptoms and other childhood disruptive behaviors. J Abnorm Child Psychol. 1998;26(4):293-309.
49. Wright KD, Waschbusch DA, Frankland BW. Combining data from parent ratings and parent interview when assessing ADHD. J Psychpathol Behav Assess. 2007;29(3):141-148.
50. Pelham WE, Evans SW, Gnagy EM, et al. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders: prevalence, factor analyses, and conditional probabilities in a special education sample. School Psych Rev. 1992;21(2):285-299.
51. Gresham FM, Elliott SN. The Social Skills Rating System Manual. Circle Pines, MN: American Guidance Systems; 1990.
52. DuPaul GJ, Rapport MD, Perriello LM. Teacher ratings of academic skills: the development of the Academic Performance Rating Scale. School Psych Rev. 1991;20:284-300.
53. Fabiano GA, Pelham WE Jr, Waschbusch DA, et al. A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. J Clin Child Adolesc Psychol. 2006;35(3):369-385.
54. Waschbusch DA, King S. Should sex-specific norms be used to assess attention-deficit/hyperactivity disorder or oppositional defiant disorder? J Consult Clin Psychol. 2006;74(1):179-185.
55. Pelham WE. Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psych Rev. 1993;22(2):199-227.
56. Pelham WE. Attention Deficit Hyperactivity Disorder: Diagnosis, Assessment, Nature, Etiology, and Treatment. Amherst, NY: Comprehensive Treatment for Attention Deficit Disorders, Inc; 2002.
57. Pelham WE, Burrows-Maclean L, Gnagy EM, et al. Transdermal methyl-phenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol. 2005;13(2):111-126. doi:10.1037/1064-1297.13.2.1 PubMed (Pubitemid 40791820)
58. Poznanski EO, Mokros HB. Children's Depression Rating Scale-Revised (CDRS-R) Manual. Los Angeles, CA: Western Psychological Services; 1995.
59. March J, Silva S, Petrycki S, et al. Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820.
60. Pelham WE, Burrows-MacLean L, Gnagy EM, et al. Behavioral and pharmacological treatment for children with ADHD [abstract]. Presented at the 113th Annual Convention of the American Psychological Association; August 18-21, 2005; Washington, DC.
61. Becker BJ. Synthesizing standardized mean-change measures. Br J Math Stat Psychol. 1988;41:257-278.
62. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
63. Pelham WE, Waschbusch DA. Assessment and treatment of attention-deficit/hyperactivity disorder (ADHD) in schools. In: Brown RT, ed. Handbook of Pediatric Psychology in Schools. Manweh, NJ: Lawrence Erlbaum Associates; 2004:405-430.
64. Pelham WE, Hoza B, Pillow DR, et al. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings. J Consult Clin Psychol. 2002;70(2):320-335.
65. Weiss MD, Virani A, Wasdell M, et al. Atomoxetine in clinical practice. Future Neurol. 2006;1(3):249-258.
66. Koot HM, Verhulst FC. Prediction of children's referral to mental health and special education services from earlier adjustment. J Child Psychol Psychiatry. 1992;33(4):717-729.
67. Sawyer MG, Rey JM, Arney FM, et al. Use of health and school-based services in Australia by young people with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1355-1363.
68. Bussing R, Zima BT, Perwien AR, et al. Children in special education programs: attention deficit hyperactivity disorder, use of services, and unmet needs. Am J Public Health. 1998;88(6):880-886.
69. Wells KC, Chi TC, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006;74(4):649-657.
70. Hoza B, Gerdes AC, Mrug S, et al. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol. 2005;34(1):74-86.
71. Frankel F, Myatt R, Cantwell DP, et al. Parent-assisted transfer of children's social skills training: effects on children with and without attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(8):1056-1064.
72. Frankel F, Feinberg D. Social problems associated with ADHD vs ODD in children referred for friendship problems. Child Psychiatry Hum Dev. 2002;33(2):125-146. doi:10.1023/A:102073024907 PubMed (Pubitemid 35340682)
73. Waschbusch DA, Kipp HL, Pelham WE Jr. Generalization of behavioral and psychostimulant treatment of attention-deficit/hyperactivity disorder (ADHD): discussion and examples. Behav Res Ther. 1998;36(7-8): 675-694.
74. Hinshaw SP. Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. Ambul Pediatr. 2007;7(suppl):91-100.
75. Pelham WE, Aronoff HR, Midlam JK, et al. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/ hyperactivity disorder. Pediatrics. 1999;103(4):e43.
76. Pelham WE, Gnagy EM, Chronis AM, et al. A comparison of morningonly and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 1999;104(6):1300-1311.
77. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1119-1127.
78. Bangs ME, Tauscher-Wisniewski S, Polzer J, et al. Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry. 2008;47(2):209-218.
79. Waxmonsky J, Pelham WE, Gnagy EM, et al. The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/ hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol. 2008;18(6):573-588.
80. Kazdin AE. Parent management training: evidence, outcomes, and issues. J Am Acad Child Adolesc Psychiatry. 1997;36(10):1349-1356.
81. Pelham WE, Fabiano G, Waxmonsky JG, et al. Adaptive treatments for children with ADHD [poster]. Presented at the Third Annual Research Conference of the Institute of Education Sciences; June 10-12, 2008; Washington, DC.
82. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969-1976.
83. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of ADD, III: lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry. 1993;32(1):199-204.
84. Kratochvil CJ, Newcorn JH, Arnold LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005;44(9):915-924.
85. Pelham WE. Behavioral and pharmacological treatment for children with ADHD: dosing and sequencing effects. Sherrill JT (Chair), Symposium: Combining Psychosocial and Psychopharmacological Interventions to Optimize Child and Adolescent Mental Health Outcomes: New Targets and Novel Strategies. Conducted at the 39th Annual Convention of the Association for Behavioral and Cognitive Therapies; November 17-20, 2005; Washington, DC.
86. Murray DW, Kollins SH, Hardy KK, et al. Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17(5):605-620.